Physical Activity Intervention for Improving Vascular Comorbidity Risk in Multiple Sclerosis

Multiple Sclerosis Clinical Trial

Official title: Physical Activity Intervention for Improving Vascular Comorbidity Risk in Multiple Sclerosis

Status Terminated

Clinical Trial Summary

Vascular comorbidities, such as high cholesterol, obesity, high blood pressure, and diabetes, are common among people with multiple sclerosis (MS), and can negatively impact disease diagnosis, treatment, and progression. Physical inactivity may be one possible reason for this increased risk and may occur through changes in cardiorespiratory fitness (the ability of the body to transport and use oxygen during sustained physical activity). While exercise training is effective for improving fitness, factors such as accessibility to facilities and financial cost may not make it a viable option for most people with MS. An alternative approach for improving fitness is by increasing daily physical activity levels. The research team has developed and tested an Internet-delivered lifestyle physical activity intervention that has been shown to improve physical activity levels among people with MS. This lifestyle intervention is a promising approach for also increasing fitness and managing vascular comorbidity risk in persons with MS. This randomized clinical trial will examine the efficacy of a 6-month lifestyle physical activity intervention on cardiorespiratory fitness and vascular comorbidity risk in persons with MS.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Multiple Sclerosis
• Sclerosis

• NCT number: NCT03944538
• Study type: Interventional
• Source: University of Ottawa
• Status: Terminated
• Phase: N/A
• Start date: July 21, 2019
• Completion date: October 20, 2020